Teva Branded Pharmaceutical Products R&d, Inc.
Clinical trials sponsored by Teva Branded Pharmaceutical Products R&d, Inc., explained in plain language.
-
New cancer drug enters human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called TEV-56278, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find safe doses and see if the drug …
Phase: PHASE1 • Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New smart inhaler trial aims to help asthma sufferers breathe easier
Disease control Recruiting nowThis study is testing a new combination asthma inhaler that contains both a steroid (fluticasone) and a fast-acting reliever (albuterol). It will compare this new inhaler against the individual medicines and a placebo over 4 weeks in 724 people aged 12 and older with asthma. The …
Phase: PHASE3 • Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC